{"id": "article-25173_0", "title": "Minimal Change Disease -- Continuing Education Activity", "content": "Minimal change disease (MCD) is one of the most common causes of idiopathic nephrotic syndrome in children. In the past, MCD was given the labels \"nil disease\" or \"lipoid nephrosis.\"In adults, MCD closely resembles. Focal Segmental Glomerulosclerosis (FSGS) under light microscopy. However, electron microscopy demonstrates abnormalities in podocyte or glomerular epithelial cells in both MCD and focal segmental glomerulosclerosis (FSGS).", "contents": "Minimal Change Disease -- Continuing Education Activity. Minimal change disease (MCD) is one of the most common causes of idiopathic nephrotic syndrome in children. In the past, MCD was given the labels \"nil disease\" or \"lipoid nephrosis.\"In adults, MCD closely resembles. Focal Segmental Glomerulosclerosis (FSGS) under light microscopy. However, electron microscopy demonstrates abnormalities in podocyte or glomerular epithelial cells in both MCD and focal segmental glomerulosclerosis (FSGS)."}
{"id": "article-25173_1", "title": "Minimal Change Disease -- Continuing Education Activity", "content": "Objectives: Identify the etiology of minimal change disease. Describe the evaluation of minimal change disease. Overview the management options available for minimal change disease. Access free multiple choice questions on this topic.", "contents": "Minimal Change Disease -- Continuing Education Activity. Objectives: Identify the etiology of minimal change disease. Describe the evaluation of minimal change disease. Overview the management options available for minimal change disease. Access free multiple choice questions on this topic."}
{"id": "article-25173_2", "title": "Minimal Change Disease -- Introduction", "content": "Minimal change disease (MCD) is one of the most common causes of idiopathic nephrotic syndrome in children. It accounts for 70% to 90% of children that present with nephrotic syndrome who are older than one year old as opposed to 10-15%\u00a0of adults who present with nephrotic syndrome. [1] Minimal change disease is distinctive for proteinuria that results in edema and intravascular volume depletion, with a good response to steroids. Minimal Change Disease has been labeled \u201cminimal change lesion,\u201d \u201cnil disease,\u201d and \u201clipoid nephrosis\u00a0(a description of lipid droplets in urine seen on light\u00a0microscopy). [2] Minimal change disease has a particularly good prognosis in pediatric patients.", "contents": "Minimal Change Disease -- Introduction. Minimal change disease (MCD) is one of the most common causes of idiopathic nephrotic syndrome in children. It accounts for 70% to 90% of children that present with nephrotic syndrome who are older than one year old as opposed to 10-15%\u00a0of adults who present with nephrotic syndrome. [1] Minimal change disease is distinctive for proteinuria that results in edema and intravascular volume depletion, with a good response to steroids. Minimal Change Disease has been labeled \u201cminimal change lesion,\u201d \u201cnil disease,\u201d and \u201clipoid nephrosis\u00a0(a description of lipid droplets in urine seen on light\u00a0microscopy). [2] Minimal change disease has a particularly good prognosis in pediatric patients."}
{"id": "article-25173_3", "title": "Minimal Change Disease -- Etiology", "content": "Mostly\u00a0minimal change disease is idiopathic (primary) but can occur secondary to exposure to other agents: Infections: Tuberculosis, syphilis, mycoplasma, ehrlichiosis, hepatitis C virus Neoplasms: Hematologic malignancies, including leukemia, Hodgkin and non-Hodgkin lymphoma Allergy: Bee and medusa stings, cat fur, fungi, poison ivy, ragweed pollen, house dust Drugs: NSAIDs, lithium, antibiotics (ampicillin, cephalosporins), immunizations, and gamma interferon Other glomerular diseases: Associated with IgA nephropathy, SLE, type 1 DM, and HIV", "contents": "Minimal Change Disease -- Etiology. Mostly\u00a0minimal change disease is idiopathic (primary) but can occur secondary to exposure to other agents: Infections: Tuberculosis, syphilis, mycoplasma, ehrlichiosis, hepatitis C virus Neoplasms: Hematologic malignancies, including leukemia, Hodgkin and non-Hodgkin lymphoma Allergy: Bee and medusa stings, cat fur, fungi, poison ivy, ragweed pollen, house dust Drugs: NSAIDs, lithium, antibiotics (ampicillin, cephalosporins), immunizations, and gamma interferon Other glomerular diseases: Associated with IgA nephropathy, SLE, type 1 DM, and HIV"}
{"id": "article-25173_4", "title": "Minimal Change Disease -- Epidemiology", "content": "Minimal change disease has an incidence of 2\u00a0to 7 new cases per 100,000 children. The exact prevalence is unknown; however, it is estimated to be about 10\u00a0to 50 cases per 100,000 children.\u00a0A male predominance (2\u00a0to 1) is noted during childhood, which disappears\u00a0during the adolescent years. Minimal change disease is not common in adults, and the exact incidence is not known. [2]", "contents": "Minimal Change Disease -- Epidemiology. Minimal change disease has an incidence of 2\u00a0to 7 new cases per 100,000 children. The exact prevalence is unknown; however, it is estimated to be about 10\u00a0to 50 cases per 100,000 children.\u00a0A male predominance (2\u00a0to 1) is noted during childhood, which disappears\u00a0during the adolescent years. Minimal change disease is not common in adults, and the exact incidence is not known. [2]"}
{"id": "article-25173_5", "title": "Minimal Change Disease -- Pathophysiology", "content": "Minimal change disease presents with a nephrotic syndrome characterized by an increased renal membrane permeability and loss of protein (primarily albumin) due to damage to the glomerular filtration barrier (GFB). The GFB is composed of fenestrated endothelium (inner layer), the glomerular basement membrane (middle layer), and an outer epithelial layer composed of podocytes. Podocytes are\u00a0epithelial cells with large cell bodies and long\u00a0foot processes that run parallel along the outside of glomerular capillaries. The space between foot processes is interspersed by cell-to-cell junctions called slit diaphragms. [3]", "contents": "Minimal Change Disease -- Pathophysiology. Minimal change disease presents with a nephrotic syndrome characterized by an increased renal membrane permeability and loss of protein (primarily albumin) due to damage to the glomerular filtration barrier (GFB). The GFB is composed of fenestrated endothelium (inner layer), the glomerular basement membrane (middle layer), and an outer epithelial layer composed of podocytes. Podocytes are\u00a0epithelial cells with large cell bodies and long\u00a0foot processes that run parallel along the outside of glomerular capillaries. The space between foot processes is interspersed by cell-to-cell junctions called slit diaphragms. [3]"}
{"id": "article-25173_6", "title": "Minimal Change Disease -- Pathophysiology", "content": "Glomerular filtration is both size-specific and charge-specific. The actin cytoskeleton of podocytes provides support to the GBM and regulates flow across the basement membrane depending on\u00a0hydrostatic pressures, molecular size, and molecular charge. [3] The apical and luminal membrane of the slit diaphragms and podocytes are coated with a sialoglycoprotein (podocalyxin) which contributes to repels negatively charged molecules such as albumin. The two outer layers of the glomerular basement membrane\u00a0are composed of heparin sulfate proteoglycans that\u00a0are also negatively charged and contribute to the\u00a0charge selectivity of the barrier. [4] Disruption\u00a0of this barrier leads to the proteinuria seen in nephrotic syndrome.", "contents": "Minimal Change Disease -- Pathophysiology. Glomerular filtration is both size-specific and charge-specific. The actin cytoskeleton of podocytes provides support to the GBM and regulates flow across the basement membrane depending on\u00a0hydrostatic pressures, molecular size, and molecular charge. [3] The apical and luminal membrane of the slit diaphragms and podocytes are coated with a sialoglycoprotein (podocalyxin) which contributes to repels negatively charged molecules such as albumin. The two outer layers of the glomerular basement membrane\u00a0are composed of heparin sulfate proteoglycans that\u00a0are also negatively charged and contribute to the\u00a0charge selectivity of the barrier. [4] Disruption\u00a0of this barrier leads to the proteinuria seen in nephrotic syndrome."}
{"id": "article-25173_7", "title": "Minimal Change Disease -- Pathophysiology", "content": "The pathogenesis of MCD is not exactly known, but it is thought to be multifactorial. Several studies have focused on the integrity and biology of podocytes. Because the actin cytoskeleton of podocytes maintains the integrity of the podocytes\u00a0by supporting the cell body and foot processes, regulation of flow across the basement membrane is controlled by a series of interactions. As a result, multiple theories have been proposed to explain the cause\u00a0of\u00a0proteinuria in MCD.\u00a0Some of the proposed theories published\u00a0include T cell dysfunction/dysregulation that leads to cytokine release and upregulation of proteins, such as CD80 and C-mip that affects the integrity of podocytes, systemic circulating factors that disrupt podocyte function,\u00a0and B- cell activation (suspected due to the efficacy of anti- CD-20 monoclonal antibodies, such as rituximab). [5] [6] [7]", "contents": "Minimal Change Disease -- Pathophysiology. The pathogenesis of MCD is not exactly known, but it is thought to be multifactorial. Several studies have focused on the integrity and biology of podocytes. Because the actin cytoskeleton of podocytes maintains the integrity of the podocytes\u00a0by supporting the cell body and foot processes, regulation of flow across the basement membrane is controlled by a series of interactions. As a result, multiple theories have been proposed to explain the cause\u00a0of\u00a0proteinuria in MCD.\u00a0Some of the proposed theories published\u00a0include T cell dysfunction/dysregulation that leads to cytokine release and upregulation of proteins, such as CD80 and C-mip that affects the integrity of podocytes, systemic circulating factors that disrupt podocyte function,\u00a0and B- cell activation (suspected due to the efficacy of anti- CD-20 monoclonal antibodies, such as rituximab). [5] [6] [7]"}
{"id": "article-25173_8", "title": "Minimal Change Disease -- Histopathology", "content": "Light microscopy of renal biopsy specimens from patients with MCD shows minimal to no change; however, electron microscopy reveals the effacement of\u00a0podocyte\u00a0foot processes.\u00a0To add to the conundrum,\u00a0immunofluorescent staining of biopsy specimens is negative, and\u00a0no immune complexes are evident.", "contents": "Minimal Change Disease -- Histopathology. Light microscopy of renal biopsy specimens from patients with MCD shows minimal to no change; however, electron microscopy reveals the effacement of\u00a0podocyte\u00a0foot processes.\u00a0To add to the conundrum,\u00a0immunofluorescent staining of biopsy specimens is negative, and\u00a0no immune complexes are evident."}
{"id": "article-25173_9", "title": "Minimal Change Disease -- History and Physical", "content": "An accurate\u00a0history and a thorough physical exam must be performed on each patient who presents with edema and proteinuria. Proteinuria and edema may be presenting symptoms of\u00a0other conditions such as diabetes mellitus, adverse medication effects, or systemic lupus erythematous. It is also important to consider the patient\u2019s age, family history, and recent illnesses.", "contents": "Minimal Change Disease -- History and Physical. An accurate\u00a0history and a thorough physical exam must be performed on each patient who presents with edema and proteinuria. Proteinuria and edema may be presenting symptoms of\u00a0other conditions such as diabetes mellitus, adverse medication effects, or systemic lupus erythematous. It is also important to consider the patient\u2019s age, family history, and recent illnesses."}
{"id": "article-25173_10", "title": "Minimal Change Disease -- History and Physical", "content": "Patients with MCD commonly present with periorbital, scrotum, labia, and/or lower extremity edema. On exam, patients may demonstrate anasarca, pericardial or pleural effusion, ascites, and abdominal pain. An affected individual is an intravascularly volume depleted and maybe oliguric, which can lead to\u00a0acute kidney injury, a\u00a0finding most frequently noted in adults. Children\u00a0often present with severe infections (sepsis, pneumonia, and peritonitis) due to the depletion of immunoglobulin. [8] Minimal change disease in adults presents with hematuria, acute kidney injury, and hypertension.", "contents": "Minimal Change Disease -- History and Physical. Patients with MCD commonly present with periorbital, scrotum, labia, and/or lower extremity edema. On exam, patients may demonstrate anasarca, pericardial or pleural effusion, ascites, and abdominal pain. An affected individual is an intravascularly volume depleted and maybe oliguric, which can lead to\u00a0acute kidney injury, a\u00a0finding most frequently noted in adults. Children\u00a0often present with severe infections (sepsis, pneumonia, and peritonitis) due to the depletion of immunoglobulin. [8] Minimal change disease in adults presents with hematuria, acute kidney injury, and hypertension."}
{"id": "article-25173_11", "title": "Minimal Change Disease -- Evaluation", "content": "Glomerulonephritis\u00a0is associated with many\u00a0diagnoses that are differentiated by histopathology or clinical presentation. [9] To establish the etiology of glomerulonephritis, one must determine whether the patient presents with nephritic or nephrotic syndrome. Nephritic syndrome is associated with hematuria,\u00a0 proteinuria, and hypertension. Nephrotic syndrome is associated with heavy proteinuria, hypoalbuminemia, peripheral edema, hyperlipidemia, and thrombotic disease.\u00a0The fluid status in patients with nephrotic syndrome alternates between hypovolemia and hypervolemia.\u00a0Hypovolemic patients may be referred to as \"underfilled\" due to the loss of albumin through proteinuria. Hypoalbuminemia leads to decreased oncotic pressure and fluid sequestration in the interstitial space. [10] Hypoalbuminemia and low oncotic pressure induce reflexes through the juxtaglomerular apparatus to compensate for intravascular fluid losses by increasing sodium absorption and water retention.\u00a0Patients with MCD are commonly hypovolemic (underfilled).", "contents": "Minimal Change Disease -- Evaluation. Glomerulonephritis\u00a0is associated with many\u00a0diagnoses that are differentiated by histopathology or clinical presentation. [9] To establish the etiology of glomerulonephritis, one must determine whether the patient presents with nephritic or nephrotic syndrome. Nephritic syndrome is associated with hematuria,\u00a0 proteinuria, and hypertension. Nephrotic syndrome is associated with heavy proteinuria, hypoalbuminemia, peripheral edema, hyperlipidemia, and thrombotic disease.\u00a0The fluid status in patients with nephrotic syndrome alternates between hypovolemia and hypervolemia.\u00a0Hypovolemic patients may be referred to as \"underfilled\" due to the loss of albumin through proteinuria. Hypoalbuminemia leads to decreased oncotic pressure and fluid sequestration in the interstitial space. [10] Hypoalbuminemia and low oncotic pressure induce reflexes through the juxtaglomerular apparatus to compensate for intravascular fluid losses by increasing sodium absorption and water retention.\u00a0Patients with MCD are commonly hypovolemic (underfilled)."}
{"id": "article-25173_12", "title": "Minimal Change Disease -- Evaluation", "content": "Hypervolemia (overfill) associated with nephrotic syndrome is due to tubular dysregulation, which increases sodium absorption and water retention. In these patients, hypoalbuminemia and decreased oncotic pressure are not the cause of edema.\u00a0 Therefore, it is important to understand each patient's volume status before initiating therapy that addresses edema.", "contents": "Minimal Change Disease -- Evaluation. Hypervolemia (overfill) associated with nephrotic syndrome is due to tubular dysregulation, which increases sodium absorption and water retention. In these patients, hypoalbuminemia and decreased oncotic pressure are not the cause of edema.\u00a0 Therefore, it is important to understand each patient's volume status before initiating therapy that addresses edema."}
{"id": "article-25173_13", "title": "Minimal Change Disease -- Evaluation", "content": "In\u00a0children, MCD\u00a0is the most\u00a0common cause of idiopathic nephrotic syndrome.\u00a0Minimal change disease is the third most common cause of idiopathic nephrotic syndrome in\u00a0adults\u00a0after focal segmental glomerular sclerosis and membranous nephropathy. An early kidney biopsy is crucial\u00a0to making the\u00a0diagnosis of MCD in adults. [1] In\u00a0children,\u00a0MCD is primarily a clinical diagnosis, and biopsy\u00a0is only required in the presence of atypical clinical features: Age of onset before 1 or after12 years old Gross hematuria Low serum C3 Marked Hypertension Elevated creatinine Renal failure without hypovolemia Positive history or serology for secondary causes Steroid resistance [2] A successful response to steroids might be anticipated in children how to present with typical clinical findings of MCD and are: Age 1-12 years old Normotensive Normal Renal Function +/- Microscopic hematuria", "contents": "Minimal Change Disease -- Evaluation. In\u00a0children, MCD\u00a0is the most\u00a0common cause of idiopathic nephrotic syndrome.\u00a0Minimal change disease is the third most common cause of idiopathic nephrotic syndrome in\u00a0adults\u00a0after focal segmental glomerular sclerosis and membranous nephropathy. An early kidney biopsy is crucial\u00a0to making the\u00a0diagnosis of MCD in adults. [1] In\u00a0children,\u00a0MCD is primarily a clinical diagnosis, and biopsy\u00a0is only required in the presence of atypical clinical features: Age of onset before 1 or after12 years old Gross hematuria Low serum C3 Marked Hypertension Elevated creatinine Renal failure without hypovolemia Positive history or serology for secondary causes Steroid resistance [2] A successful response to steroids might be anticipated in children how to present with typical clinical findings of MCD and are: Age 1-12 years old Normotensive Normal Renal Function +/- Microscopic hematuria"}
{"id": "article-25173_14", "title": "Minimal Change Disease -- Evaluation -- Basic labs:", "content": "Urinalysis/ Urine microscopy : Dipstick will show 3+/4+ proteinuria. A urine dipstick and urinalysis (UA) are often the initial tests obtained to screen for MCD.\u00a0In MCD, the urine typically looks frothy secondary to proteinuria, and the microscopy shows oval fat bodies and fatty casts. Dysmorphic RBCs, acanthocytes, abnormal casts, and proteinuria are findings suggestive of glomerular injury not frequently seen in MCD. [9] Keep in mind that a urine dipstick has its limitations. The dipstick cannot identify\u00a0the extent or type of proteinuria as it primarily detects albumin and does not detect low molecular weight proteins. [11] False-positive test results are noted in the presence of mucus, blood, pus, alkalinity, or\u00a0concentration. [12] A 24-hour urine collection is required to quantitate urinary protein.", "contents": "Minimal Change Disease -- Evaluation -- Basic labs:. Urinalysis/ Urine microscopy : Dipstick will show 3+/4+ proteinuria. A urine dipstick and urinalysis (UA) are often the initial tests obtained to screen for MCD.\u00a0In MCD, the urine typically looks frothy secondary to proteinuria, and the microscopy shows oval fat bodies and fatty casts. Dysmorphic RBCs, acanthocytes, abnormal casts, and proteinuria are findings suggestive of glomerular injury not frequently seen in MCD. [9] Keep in mind that a urine dipstick has its limitations. The dipstick cannot identify\u00a0the extent or type of proteinuria as it primarily detects albumin and does not detect low molecular weight proteins. [11] False-positive test results are noted in the presence of mucus, blood, pus, alkalinity, or\u00a0concentration. [12] A 24-hour urine collection is required to quantitate urinary protein."}
{"id": "article-25173_15", "title": "Minimal Change Disease -- Evaluation -- Basic labs:", "content": "Urine collection: A spot protein/creatinine ratio greater than 200 mg/mmol in children and\u00a0protein/creatinine ratio>300-350mg/mmol in adults is consistent with nephrotic syndrome, as is a 24-hour urine collection that reveals a total protein\u00a0greater than 3\u00a0to 3.5 g/24hour in adults. A report of measuring protein output as gms/m2/hr accounts for differences in body mass. A measurement of\u00a040mg/m2/hour or greater (1gm/m2/24hour) is indicative of proteinuria consistent with nephrotic syndrome in children. Microscopic hematuria is present in 10% to 30% of adults. [13]", "contents": "Minimal Change Disease -- Evaluation -- Basic labs:. Urine collection: A spot protein/creatinine ratio greater than 200 mg/mmol in children and\u00a0protein/creatinine ratio>300-350mg/mmol in adults is consistent with nephrotic syndrome, as is a 24-hour urine collection that reveals a total protein\u00a0greater than 3\u00a0to 3.5 g/24hour in adults. A report of measuring protein output as gms/m2/hr accounts for differences in body mass. A measurement of\u00a040mg/m2/hour or greater (1gm/m2/24hour) is indicative of proteinuria consistent with nephrotic syndrome in children. Microscopic hematuria is present in 10% to 30% of adults. [13]"}
{"id": "article-25173_16", "title": "Minimal Change Disease -- Evaluation -- Basic labs:", "content": "Complete metabolic panel (CMP): CMP\u00a0demonstrates a low total protein, low albumin (frequently <2.5 g/dl), and low total calcium\u00a0(ionized calcium binds to albumin, and albumin is low).", "contents": "Minimal Change Disease -- Evaluation -- Basic labs:. Complete metabolic panel (CMP): CMP\u00a0demonstrates a low total protein, low albumin (frequently <2.5 g/dl), and low total calcium\u00a0(ionized calcium binds to albumin, and albumin is low)."}
{"id": "article-25173_17", "title": "Minimal Change Disease -- Evaluation -- Basic labs:", "content": "Complete blood count (CBC): CBC  will show hemoconcentration and thrombocytosis. This is seen due to the intravascular volume contraction from fluid sequestration into the interstitial space.", "contents": "Minimal Change Disease -- Evaluation -- Basic labs:. Complete blood count (CBC): CBC  will show hemoconcentration and thrombocytosis. This is seen due to the intravascular volume contraction from fluid sequestration into the interstitial space."}
{"id": "article-25173_18", "title": "Minimal Change Disease -- Evaluation -- Basic labs:", "content": "Total cholesterol and triglyceride levels: These\u00a0are increased due to an increase in hepatic lipoprotein synthesis as a result of low oncotic pressures. [3]", "contents": "Minimal Change Disease -- Evaluation -- Basic labs:. Total cholesterol and triglyceride levels: These\u00a0are increased due to an increase in hepatic lipoprotein synthesis as a result of low oncotic pressures. [3]"}
{"id": "article-25173_19", "title": "Minimal Change Disease -- Evaluation -- Labs to rule out secondary causes:", "content": "Antinuclear antibodies Hepatitis B and C serologic tests Serologic test for syphilis (e.g., rapid plasma reagin) HIV antibody test Complement levels (CH50, C3, C4)", "contents": "Minimal Change Disease -- Evaluation -- Labs to rule out secondary causes:. Antinuclear antibodies Hepatitis B and C serologic tests Serologic test for syphilis (e.g., rapid plasma reagin) HIV antibody test Complement levels (CH50, C3, C4)"}
{"id": "article-25173_20", "title": "Minimal Change Disease -- Treatment / Management", "content": "The initial cornerstone treatment for\u00a0minimal change disease is steroids. Children frequently achieve remission with steroids within 4 weeks vs. adults\u00a0who achieve remission in\u00a0two months or more [2] .\u00a0The incidence of relapse is high in children and adults.", "contents": "Minimal Change Disease -- Treatment / Management. The initial cornerstone treatment for\u00a0minimal change disease is steroids. Children frequently achieve remission with steroids within 4 weeks vs. adults\u00a0who achieve remission in\u00a0two months or more [2] .\u00a0The incidence of relapse is high in children and adults."}
{"id": "article-25173_21", "title": "Minimal Change Disease -- Treatment / Management -- Children", "content": "Initial prednisone therapy is 60 mg/m^2(or 2 mg/kg) administered daily for 4-6 weeks (maximum dose, 60 mg/day), or 40 mg/m2/(or 1.5 mg/kg) on alternate days for 2-5 months taper. Reduce the dose by 5\u00a0mg/m2\u00a0to 10 mg/m2 each week for another four weeks, then stop, with a minimum duration of 12 weeks [14] .", "contents": "Minimal Change Disease -- Treatment / Management -- Children. Initial prednisone therapy is 60 mg/m^2(or 2 mg/kg) administered daily for 4-6 weeks (maximum dose, 60 mg/day), or 40 mg/m2/(or 1.5 mg/kg) on alternate days for 2-5 months taper. Reduce the dose by 5\u00a0mg/m2\u00a0to 10 mg/m2 each week for another four weeks, then stop, with a minimum duration of 12 weeks [14] ."}
{"id": "article-25173_22", "title": "Minimal Change Disease -- Treatment / Management -- Adults", "content": "Initial prednisone treatment is 1mg/kg per day or 2 mg/kg/kg every other day (max 80mg/day or 120 mg every other day) for 4-16 weeks. Taper slowly over a course of 6 months after remission [13] .", "contents": "Minimal Change Disease -- Treatment / Management -- Adults. Initial prednisone treatment is 1mg/kg per day or 2 mg/kg/kg every other day (max 80mg/day or 120 mg every other day) for 4-16 weeks. Taper slowly over a course of 6 months after remission [13] ."}
{"id": "article-25173_23", "title": "Minimal Change Disease -- Treatment / Management -- Patients Who Relapse Demonstrate the following", "content": "Steroid resistance is noted as the persistence of proteinuria in children after 4 weeks of prednisone and after 16 weeks for adults. Frequent relapses occur, which are defined as two or more relapses in the first\u00a0six months of\u00a0presentation or\u00a0four or more relapses within any 12 months Steroid dependency is defined as relapses that occur during the tapering phase of steroid therapy or less than two weeks after\u00a0discontinuing steroids Relapse nephrosis -\u00a0> 2+ proteinuria on 3 consecutive days Prednisolone should be restarted if there is a relapse: 2 mg/kg daily (maximum 60 mg) until in remission for 3 days, then 1.5 mg/kg alternate days for 4 weeks, then stop or taper the dose over 4-8 weeks.", "contents": "Minimal Change Disease -- Treatment / Management -- Patients Who Relapse Demonstrate the following. Steroid resistance is noted as the persistence of proteinuria in children after 4 weeks of prednisone and after 16 weeks for adults. Frequent relapses occur, which are defined as two or more relapses in the first\u00a0six months of\u00a0presentation or\u00a0four or more relapses within any 12 months Steroid dependency is defined as relapses that occur during the tapering phase of steroid therapy or less than two weeks after\u00a0discontinuing steroids Relapse nephrosis -\u00a0> 2+ proteinuria on 3 consecutive days Prednisolone should be restarted if there is a relapse: 2 mg/kg daily (maximum 60 mg) until in remission for 3 days, then 1.5 mg/kg alternate days for 4 weeks, then stop or taper the dose over 4-8 weeks."}
{"id": "article-25173_24", "title": "Minimal Change Disease -- Treatment / Management -- For frequent relapses/ steroid-dependent (steroid-sparing agents)", "content": "Cyclophosphamide: the dose of 2 mg/kg/ day for 8\u00a0to 12 weeks (should be started after reaching remission with the steroid)- potential gonadal toxicity, alopecia, bone marrow suppression. Cyclosporine: At a dose of 4\u00a0to 5 mg/kg/day, usually for 1-2 years. Levels should be monitored after 1 to 2 weeks. Aim for a trough of 70\u00a0to 150. Can cause nephrotoxicity, hirsutism, hypertension, and gingival hyperplasia.", "contents": "Minimal Change Disease -- Treatment / Management -- For frequent relapses/ steroid-dependent (steroid-sparing agents). Cyclophosphamide: the dose of 2 mg/kg/ day for 8\u00a0to 12 weeks (should be started after reaching remission with the steroid)- potential gonadal toxicity, alopecia, bone marrow suppression. Cyclosporine: At a dose of 4\u00a0to 5 mg/kg/day, usually for 1-2 years. Levels should be monitored after 1 to 2 weeks. Aim for a trough of 70\u00a0to 150. Can cause nephrotoxicity, hirsutism, hypertension, and gingival hyperplasia."}
{"id": "article-25173_25", "title": "Minimal Change Disease -- Treatment / Management -- If intolerant to the above-mentioned drugs, can give :", "content": "Mycophenolate mofetil (MMF): Doses of 500\u00a0to 1000 mg two times a day for 1\u00a0to 2 years. Should be monitored for leukopenia. [14] Rituximab (chimeric monoclonal antibody): 375\u00a0mg/weekly for 1\u00a0to 4 doses. [15] Side effects such as fulminant myocarditis, pulmonary fibrosis, fatal Pneumocystis jirovecii infections, ulcerative colitis, and allergic reactions. [2]", "contents": "Minimal Change Disease -- Treatment / Management -- If intolerant to the above-mentioned drugs, can give :. Mycophenolate mofetil (MMF): Doses of 500\u00a0to 1000 mg two times a day for 1\u00a0to 2 years. Should be monitored for leukopenia. [14] Rituximab (chimeric monoclonal antibody): 375\u00a0mg/weekly for 1\u00a0to 4 doses. [15] Side effects such as fulminant myocarditis, pulmonary fibrosis, fatal Pneumocystis jirovecii infections, ulcerative colitis, and allergic reactions. [2]"}
{"id": "article-25173_26", "title": "Minimal Change Disease -- Differential Diagnosis", "content": "The differential diagnosis includes: Cardiac: Heart failure Hepatic: Liver failure, hepatocellular cirrhosis Digestive: Protein-losing enteropathy, malnutrition Renal: acute Glomerulonephritis, renal failure Immune: Angioedema, anaphylaxis Lymphatic: Primary/secondary lymphedema, congenital lymphedema These diagnoses present with edema secondary to decreased intravascular oncotic pressure.", "contents": "Minimal Change Disease -- Differential Diagnosis. The differential diagnosis includes: Cardiac: Heart failure Hepatic: Liver failure, hepatocellular cirrhosis Digestive: Protein-losing enteropathy, malnutrition Renal: acute Glomerulonephritis, renal failure Immune: Angioedema, anaphylaxis Lymphatic: Primary/secondary lymphedema, congenital lymphedema These diagnoses present with edema secondary to decreased intravascular oncotic pressure."}
{"id": "article-25173_27", "title": "Minimal Change Disease -- Prognosis", "content": "Minimal change disease has very good prognosis for all ages if there is a response to corticosteroid therapy. The\u00a0primary morbidity\u00a0is related to the adverse effects of the medications. [2]", "contents": "Minimal Change Disease -- Prognosis. Minimal change disease has very good prognosis for all ages if there is a response to corticosteroid therapy. The\u00a0primary morbidity\u00a0is related to the adverse effects of the medications. [2]"}
{"id": "article-25173_28", "title": "Minimal Change Disease -- Complications", "content": "These complications are mainly secondary to the extensive proteinuria that is seen with this disease. Children and adults with MCD are at risk for developing complications such as: Hypovolemia Infections (pneumonia, peritonitis, sepsis): Secondary to the loss of immunoglobulins (IgG) and complement factors via the urine. Also, there is decreased opsonization of capsulated organisms. Venous thromboembolism: due to a decrease in antithrombin III, protein S, plasminogen, and increase in prothrombotic factors. [11] Hyperlipidemia Acute kidney injury: From the intravascular volume depletion.", "contents": "Minimal Change Disease -- Complications. These complications are mainly secondary to the extensive proteinuria that is seen with this disease. Children and adults with MCD are at risk for developing complications such as: Hypovolemia Infections (pneumonia, peritonitis, sepsis): Secondary to the loss of immunoglobulins (IgG) and complement factors via the urine. Also, there is decreased opsonization of capsulated organisms. Venous thromboembolism: due to a decrease in antithrombin III, protein S, plasminogen, and increase in prothrombotic factors. [11] Hyperlipidemia Acute kidney injury: From the intravascular volume depletion."}
{"id": "article-25173_29", "title": "Minimal Change Disease -- Deterrence and Patient Education", "content": "Patients with acute and active disease should have low sodium in their diet and should also be encouraged to restrict their fluid intake.", "contents": "Minimal Change Disease -- Deterrence and Patient Education. Patients with acute and active disease should have low sodium in their diet and should also be encouraged to restrict their fluid intake."}
{"id": "article-25173_30", "title": "Minimal Change Disease -- Enhancing Healthcare Team Outcomes", "content": "Minimal change disease is frequently encountered as the most common cause of nephrotic syndrome in children, and it is the third most common cause of nephrotic syndrome in adults. An interdisciplinary team including a nephrologist, pharmacist, primary care, and nurse is essential for detection, diagnosis, and optimizing therapy. In children, MCD presents with distinct clinical features. However, in adults, the clinical features may vary. It is important to recognize these clinical and lab findings associated with MCD to tailor and optimize therapy\u00a0in MCD\u00a0subgroups.", "contents": "Minimal Change Disease -- Enhancing Healthcare Team Outcomes. Minimal change disease is frequently encountered as the most common cause of nephrotic syndrome in children, and it is the third most common cause of nephrotic syndrome in adults. An interdisciplinary team including a nephrologist, pharmacist, primary care, and nurse is essential for detection, diagnosis, and optimizing therapy. In children, MCD presents with distinct clinical features. However, in adults, the clinical features may vary. It is important to recognize these clinical and lab findings associated with MCD to tailor and optimize therapy\u00a0in MCD\u00a0subgroups."}
{"id": "article-25173_31", "title": "Minimal Change Disease -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Minimal Change Disease -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}